Results 101 to 110 of about 1,514 (136)

Gliptin-Associated Bullous Pemphigoid - A Series of 3 Cases. [PDF]

Indian Dermatol Online J
Bhunya PK, Sil S, Sil A, Ghosh AP, Das NK.   +4 more
europepmc   +1 more source

Eosinophilic annular erythema: report of four cases in adults and update of the literature. [PDF]

An Bras Dermatol
Cohen Sabban EN, Cabo HA, Peralta R, Salerni G, Stengel F, Gilaberte Y, Maronna E.   +6 more
europepmc   +1 more source

Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement. [PDF]

World Allergy Organ J
Romano A, Valluzzi RL, Alvarez-Cuesta E, Ansotegui I, Asero R, Barbaud A, Bartra J, Bavbek S, Cahill KN, Demoly P, Doña I, Guzmán Meléndez MA, Kidon M, Li L, Madrigal-Burgaleta R, Makowska JS, Park HS, Picado C, Sanak M, Taniguchi M, White AA, Steering Committee Authors, Atanaskovic-Markovic M, Attanasi M, Aun MV, Berges-Gimeno MP, Bernal-Rubio L, Brockow K, Bustamante L, Caffarelli C, Chang YS, Chikhladze M, Ensina LF, Fernandes BN, Garvey LH, Giavina-Bianchi P, Gómes E, Kuyucu S, Labella M, Mayorga C, Mori F, Pagani M, Palma-Pino V, Parisi C, Phillips E, Powell E, Ramien M, Savic L, Solano-Solares E, Tanno LK, Vazquez-Revuelta P, Watts T, Yamaguchi M, Review Panel Members.   +53 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption

American Journal of Clinical Dermatology, 2020
A fixed drug eruption (FDE) is a relatively common reaction associated with more than 100 medications. It is defined as a same-site recurrence with exposure to a particular medication. The primary approach and treatment for all types of FDEs are to identify and remove the causative agent, often accomplished by a thorough history of medication and other
Shreya Patel, A. John, M. Handler, R. Schwartz   +3 more
semanticscholar   +4 more sources

Rapidly progressing generalized bullous fixed drug eruption after the first dose of COVID‐19 messenger RNA vaccination

Journal of Dermatology, 2023
Generalized bullous fixed drug eruption (GBFDE) is a rare type of life‐threatening severe cutaneous adverse reaction that is considered a medical emergency because of its potential lethality.
Tae-Gyun Kim, Sooyeon Choi
exaly   +2 more sources

Generalized Bullous Fixed Drug Eruption: A Systematic Review.

The Journal of Allergy and Clinical Immunology: In Practice
BACKGROUND Generalized Bullous Fixed Drug Eruption (GBFDE) is a Severe Cutaneous Adverse Reaction (SCAR) characterized by widespread plaques with bullae.
L. Loo, N. Ngiam, R. Sultana, H. Lee
semanticscholar   +3 more sources

Generalized Bullous Fixed Drug Eruption

Dermatitis®, 2023
L. Chai, Zehu Liu
semanticscholar   +3 more sources

Generalized bullous fixed drug eruption.

European Journal of Internal Medicine
Li Chen, Jun Zhou, Lei Yao
semanticscholar   +3 more sources

Fixed Drug Eruptions and Generalized Bullous Fixed Drug Eruptions

Updates in Clinical Dermatology, 2022
Yung-Tsu Cho, Chia-Yu Chu, Chu Chia-Yu   +2 more
exaly   +2 more sources